Immunological research focusing on dengue, malaria and tuberculosis will be supported by new grants from the US National Institutes of Health.
The research, to be conducted at the La Jolla Institute for Allergy & Immunology in California, will focus on identifying epitopes – pieces of a virus or microbe against which the human immune system can launch an attack. The La Jolla researchers aim to identify epitopes that could be potential targets in the development of vaccines.
Alessandro Sette, an expert on vaccine development and director of the La Jolla Institute’s Center for Infectious Disease, will lead the research.
